DeepakRajput

Adverse Drug Reactions (ADRs) refer to unintended and harmful reactions that occur in response to the administration of medications at normal therapeutic doses. These reactions can manifest in various forms, ranging from mild discomfort to severe adverse effects, and they can occur immediately after drug intake or after prolonged use. ADRs are distinct from the … Read more

The Pharmacovigilance Program of India (PvPI) is a national initiative launched by the Government of India to ensure the safety of medicines used by the Indian population. It aims to monitor, detect, assess, and prevent adverse drug reactions (ADRs) and ensure that medicines available in the market are safe and effective for public use. PvPI … Read more

The WHO International Drug Monitoring Programme, Programme for International Drug Monitoring (PIDM) is a global initiative established by the World Health Organization (WHO) to improve patient safety by monitoring the safety of medicinal products worldwide. Launched in 1968 in response to the thalidomide disaster, the program seeks to detect, assess, understand, and prevent adverse effects … Read more

Safety monitoring of medicines, often referred to as pharmacovigilance, is a critical process that ensures the safe and effective use of pharmaceutical products throughout their lifecycle. While clinical trials provide valuable insights into a drug’s efficacy and safety, these trials are limited in terms of the number of patients, the duration of the study, and … Read more

The World Health Organization (WHO) took a leading role in global pharmacovigilance efforts. In 1968, WHO established its International Drug Monitoring Programme, which initially involved ten countries (Australia, Canada, Denmark, Ireland, Netherlands, New Zealand, Sweden, United Kingdom, United States, West Germany (now part of Germany)). This program aimed to improve drug safety by encouraging countries … Read more